The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...

Patients suffering from refractory ventricular tachycardia, a life-threating heart condition, who are not suitable for ...

Approval was supported by the phase 3 LANDI-PED study, which demonstrated significant heart rate reduction and conversion to normal sinus rhythm in pediatric patients.

Shares of Milestone Pharmaceuticals Inc. gained 25.4% in premarket trading on Monday after the company said its experimental treatment for paroxysmal supraventricular tachycardia met the primary ...

Please provide your email address to receive an email when new articles are posted on . A fast-acting nasal spray was safe and effective for patients self-treating for repeated episodes of paroxysmal ...

Medically reviewed by Angela Ryan Lee, MDMedically reviewed by Angela Ryan Lee, MD Tachycardia is the medical term for an elevated resting heart rate, which can occur when your heart beats more than ...

Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced details on ...

Clinical trial evaluating a novel, non-invasive radiation treatment for ventricular tachycardia refractory to medication and catheter ablation The UAB Departments of Radiation Oncology and Cardiology ...

Consultation, woman in pain The patient experienced random short bursts of chest pain and felt that she was going to pass out, starting 2 weeks before ED visit. A 24-year-old woman presents to the ...

“For many years, implantable cardioverter defibrillators have been one of the primary treatment options for patients with ventricular arrhythmias,” said Dr. Andrea Natale, executive medical director ...